From: X chromosome aneuploidy in the Alzheimer’s disease brain
Controls | Chromosomes/percent aneuploidy (losses + gains) | ||||||
---|---|---|---|---|---|---|---|
No (age, years) | 1 | 7 | 11 | 16 | 17 | 18 | X |
Control | |||||||
AK1(76) | 0.8 | 0.9 | 0.3 | 0.4 | 1.2 | 1.4 | 0.9 |
AK2 (78) | 0.9 | 0.6 | 1.5 | 0.6 | 0.5 | 1.2 | 1.6 |
AK3 (80) | 0.5 | 1.0 | 0.9 | 0.6 | 0.8 | 0.8 | 0.7 |
AK4 (82) | 0.3 | 1.4 | 0.6 | 1.6 | 0.7 | 1.3 | 1.2 |
AK5 (79) | 0.6 | 0.9 | 0.8 | 0.8 | 0.8 | 1.0 | 1.4 |
AK6 (69) | 0.2 | 0.4 | 0.9 | 0.5 | 0.6 | 0.4 | 0.8 |
AK7 (71) | 0.4 | 0.6 | 0.3 | 0.4 | 0.3 | 0.5 | 1.2 |
AK8 (70) | 0.3 | 0.2 | 0/5 | 0.6 | 0.5 | 0.2 | 2.6 |
AK9 (82) | 0.6 | 0.4 | 0.3 | 0.7 | 0.5 | 0.3 | 1.2 |
AK10 (79) | 0.5 | 0.3 | 0.7 | 0.2 | 0.4 | 1.1 | 1.6 |
The mean | 0.51 | 0.67 | 0.68 | 0.64 | 0.63 | 0.82 | 1.32 |
(95% CI) | (0.35-0.67) | (0.40-0.94) | (0.41-0.95) | (0.37-0.91) | (0.44-0.81) | (0.50-1.14) | (0.92-1.71) |
AD | |||||||
AD1 (72) | 0.5 | 1.3 | 1.7 | 0.3 | 0.8 | 0.5 | 1.0 |
AD2 (78) | 0.2 | 1.2 | 0.7 | 0.9 | 0.7 | 0.3 | 1.0 |
AD3 (80) | 0.4 | 2.7 | 0.5 | 0.8 | 1.4 | 1.4 | 1.6 |
AD4 (80) | 1.0 | 0.9 | 0.9 | 2.3 | 0.9 | 1.1 | 2.3 |
AD5 (88) | 1.3 | 2.3 | 1.6 | 2.5 | 1.1 | 1.6 | 3.9 |
AD6(82) | 0.9 | 0.8 | 0.6 | 0.7 | 0.4 | 0.5 | 4 |
AD7 (76) | 1.1 | 0.4 | 0.6 | 0.4 | 0.4 | 0.3 | 3.3 |
AD8 (81) | 0.6 | 0.7 | 0.4 | 0.5 | 0.5 | 1.4 | 2.7 |
AD9 (69) | 0.7 | 0.9 | 0.8 | 0.4 | 1.2 | 0.6 | 4.3 |
AD10 (72) | 1.2 | 1.0 | 1.1 | 0.5 | 1.4 | 0.9 | 3.7 |
The mean | 0.79 | 1.22 | 0.89 | 1.53 | 0.88 | 0.86 | 2.78 |
(95% CI) | (0.53-1.05) | (0.70-1.74) | (0.57-1.21) | (0.72-2.34) | (0.60-1.15) | (0.51-1.21) | (1.88-3.68) |
P value (Mann-Whitney U test) | 0.075 | 0.053 | 0.273 | 0.597 | 0.162 | 0.733 | 0.013 |
Shapiro-Wilk’s W test for normality (outliers excluded) | 0.838 | 2.676 | 0.105 | 0.731 | 0.32 | 0.2 | 0.226 |
P value (t test) | 0.054 | 0.047 | 0.27 | 0.313 | 0.106 | 0.85 | 0.003 |